View Older Stories View More Recent Stories

Nov 1, 2019 07:15AM CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Oct 30, 2019 07:30AM CytoSorbents to Report Q3 2019 Operating and Financial Results
Oct 22, 2019 08:12AM CytoSorbents Awarded Approximately $3.0 Million by the U.S. Air Force to Advance Development of the K+ontrol System to Treat Severe Hyperkalemia
Oct 10, 2019 07:00AM CytoSorbents to Present at The MicroCap Rodeo Investor Conference
Oct 4, 2019 07:09AM Cytosorbents (CTSO) will present data from new study on cost effectiveness of CytoSorb when used intraoperatively to remove ticagrelor in patients undergoing emergency open heart surgery
Oct 4, 2019 07:08AM CytoSorb® Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac Surgery
Oct 2, 2019 08:24AM CytoSorbents Announces Positive Surgical Outcomes From CytoSorb Removal Of Antithrombotics In Emergency Cardiothoracic Surgery
Sep 25, 2019 06:58AM CytoSorbents Highlights Survival Benefit of CytoSorb Therapy in Septic Shock
Sep 16, 2019 07:00AM First Study to Evaluate CytoSorb in Cytokine Release Syndrome (CRS) Following CAR T-cell Immunotherapy to Commence
Sep 13, 2019 07:08AM World Sepsis Day 2019: CytoSorbents Highlights Its Support of Multiple Organizations In the Fight Against Sepsis
Sep 9, 2019 07:00AM CytoSorbents to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 28, 2019 09:51AM CytoSorbents Highlights Recent Published Studies on CytoSorb
Aug 15, 2019 01:54PM CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022
Aug 13, 2019 07:08AM CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica
Aug 6, 2019 04:15PM CytoSorbents Reports Record Second Quarter 2019 Financial Results
Aug 5, 2019 05:00PM CytoSorbents Announces Amendment to Loan Agreement with Bridge Bank, Receives an Additional $5 Million Cash from New Term Loan
Jul 30, 2019 07:00AM CytoSorbents to Report Q2 2019 Operating and Financial Results
Jun 18, 2019 06:30AM CytoSorbents to Present at the Raymond James Life Sciences and MedTech Conference
Jun 11, 2019 07:00AM CytoSorbents to Present at the Three Part Advisors 2019 East Coast IDEAS Investor Conference
Jun 3, 2019 07:00AM CytoSorbents to Present at the Jefferies 2019 Global Healthcare Conference
May 20, 2019 07:00AM CytoSorbents to Participate at the B. Riley FBR 20th Annual Institutional Investor Conference
May 7, 2019 04:15PM CytoSorbents Reports First Quarter 2019 Financial Results and Provides Second Quarter 2019 Guidance
May 1, 2019 07:00AM CytoSorbents to Report Q1 2019 Operating and Financial Results
Apr 24, 2019 07:08AM CytoSorbents Highlights the 6th International CytoSorb Users' Meeting and Recent Activities at the 2019 ISICEM and EuroELSO Conferences
Apr 8, 2019 05:30AM CytoSorbents to Present at the H.C. Wainwright Global Life Sciences Conference 2019 London
Mar 25, 2019 07:10AM Israel Approves CytoSorb Registration, CytoSorbents Announces Gad Medical as Distributor
Mar 7, 2019 04:15PM CytoSorbents Achieves Record Revenue and Product Sales Growth in 2018
Mar 6, 2019 07:00AM CytoSorbents to Present at the Cowen 39th Annual Health Care Conference
Mar 5, 2019 07:10AM CytoSorbents Expands Direct Sales to Poland, the Nordics, and the Netherlands
Feb 28, 2019 07:00AM CytoSorbents to Report Fiscal 2018 Operating and Financial Results
Feb 25, 2019 07:08AM CytoSorbents to Participate at the 8th Annual SVB Leerink Global Healthcare Conference
Feb 5, 2019 07:00AM CytoSorbents to Present at the 21st Annual BIO CEO & Investor Conference
Feb 4, 2019 06:58AM Cytosorbents (CTSO) Announces DSMB Recommends Continuation of REMOVE Endocarditis Trial
Feb 4, 2019 06:58AM CytoSorbents Announces the Data Safety Monitoring Board Recommends Continuation of REMOVE Endocarditis Trial
Jan 22, 2019 07:08AM CytoSorbents Announces Expansion of CytoSorb® Partnership with Fresenius Medical Care
Jan 7, 2019 09:20AM CytoSorbents Issues Stockholder Letter with Preliminary 2018 Financial Results
Jan 4, 2019 07:00AM CytoSorbents To Highlight Progress at Biotech Showcase 2019
Dec 21, 2018 08:45AM CytoSorbents To Receive $619,546 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program
Nov 26, 2018 07:00AM CytoSorbents to Present at the 30th Annual Piper Jaffray Healthcare Conference
Nov 19, 2018 07:08AM CytoSorbents Recognized Again as One of the Fastest Growing Companies in North America on Deloitte's 2018 Technology Fast 500™
Nov 12, 2018 07:08AM CytoSorbents to Present at the Stifel, Jefferies, and Canaccord Investor Conferences This Week
Nov 6, 2018 04:15PM CytoSorbents Reports Third Quarter 2018 Financial Results
Oct 31, 2018 07:00AM CytoSorbents to Report Q3 2018 Operating and Financial Results
Oct 18, 2018 09:31AM CytoSorbents to Showcase CytoSorb® at Two Key European Medical Conferences
Oct 3, 2018 07:10AM CytoSorbents to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 20, 2018 07:55AM CytoSorb® Assigned Dedicated Procedure Code in Switzerland
Sep 13, 2018 07:08AM World Sepsis Day 2018: CytoSorbents Sponsors the Sepsis Heroes Gala and the Roger Bone Award for Excellence in Sepsis Research
Sep 4, 2018 07:08AM Cytosorbents (CTSO) Reports FDA Approval for REFRESH 2-AKI Protocol Amendment
Sep 4, 2018 07:05AM CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA
Aug 28, 2018 07:05AM CytoSorbents to Present at the B. Riley FBR Healthcare Conference and the H.C. Wainwright 20th Annual Global Investment Conference
View More Recent Stories View Older Stories